Ultrasensitive variant detection with ddPCR and sRCA
March 7, 2025 @ 14:00 – 15:00 CET
Clinical Genomics Webinar Series
Clinical Genomics Uppsala is hosting this webinar as part of the webinar series by the Clinical Genomics Platform
The webinar will focus on Rare tumor-specific mutations are valuable markers for tracking disease progression and therapy responses. As disease relapse remains a major challenge in Myelodysplastic Syndrome, the need for ultrasensitive assay techniques for detecting these very low frequency mutations are needed to detect relapse at the earliest time possible.
In Clinical Genomics Uppsala we explore superRCA assays—an advanced, highly sensitive, and cost-effective amplification technology, in a retrospective study in patients with MDS, monitoring the pre-identified patients mutations after hematopoietic stem-cell transplantation. This method has shown a very high sensitivity, enables detection of DNA variants at very low frequencies using standard flow cytometry, and the results and performance was compared with the results of ddPCR, commonly used method in the clinic.
Everyone is welcome so feel free to spread the details with anyone who may be interested. Hope to see you there!
Host: Malin Melin, co-PD
Invited speakers: Lei Chen, Rarity Bioscience and Sara Löfgren, Clinical Genomics Uppsala
Google Calendar 
